+

WO2001055063A1 - Novel bisadamantane compounds, process for preparing the same, and novel biadamantane derivatives - Google Patents

Novel bisadamantane compounds, process for preparing the same, and novel biadamantane derivatives Download PDF

Info

Publication number
WO2001055063A1
WO2001055063A1 PCT/JP2001/000355 JP0100355W WO0155063A1 WO 2001055063 A1 WO2001055063 A1 WO 2001055063A1 JP 0100355 W JP0100355 W JP 0100355W WO 0155063 A1 WO0155063 A1 WO 0155063A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
methyladamantyl
adamantyl
general formula
biadamantane
Prior art date
Application number
PCT/JP2001/000355
Other languages
French (fr)
Japanese (ja)
Inventor
Shunji Katai
Shintaro Suzuki
Original Assignee
Idemitsu Petrochemical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2000015341A external-priority patent/JP2001206859A/en
Priority claimed from JP2000065930A external-priority patent/JP2001253853A/en
Application filed by Idemitsu Petrochemical Co., Ltd. filed Critical Idemitsu Petrochemical Co., Ltd.
Publication of WO2001055063A1 publication Critical patent/WO2001055063A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C13/00Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
    • C07C13/28Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
    • C07C13/32Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings
    • C07C13/54Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with three condensed rings
    • C07C13/605Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with three condensed rings with a bridged ring system
    • C07C13/615Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with three condensed rings with a bridged ring system with an adamantane ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/753Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring of polycyclic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/70Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74Adamantanes

Definitions

  • the present invention relates to a novel (bis) adamantane-based compound which is a novel 2- (2-methyladamantyl) -12'-adamantylmethane-based compound, a method for producing the same, and a method for producing 3,3, dialkoxycarbone.
  • ' Relates to a new biadamantane derivative that is biadamantane. More specifically, a 2- (2-methyladamantyl) -12'-adamantyl methane compound, which has excellent heat resistance, water resistance and optical properties, and is useful as a component in coating materials and optical materials, etc.
  • the present invention relates to a novel biadamantane derivative which is well-produced, and which has excellent solubility in various solvents while maintaining the properties of biadamantans.
  • adamantanes have a very stable carbon skeleton and exhibit a unique function, so that they can be used for various applications.
  • optical disk substrates, optical fibers, It is used for lenses and the like Japanese Unexamined Patent Publication No. Hei 9-310207, Japanese Unexamined Patent Publication No. Hei 6-304504.
  • adamantane is mainly composed of a polymer having a monoadamantane compound as a monomer, and a substance having two or more adamantane skeletons and a derivative thereof are known, but the adamantane skeleton has a methylene group.
  • adamantane skeleton has a methylene group.
  • biadamantanes having two or more adamantane skeletons are more expensive. Heat resistance and unique functions are expected.
  • the present invention provides a novel asymmetric bisadamanone-based compound having an adamantane skeleton bonded via a methylene group, which is excellent in heat resistance, water resistance, optical properties, and the like;
  • An object of the present invention is to provide a novel biadamantane which is excellent in water resistance and optical properties and is excellent in solubility in various solvents.
  • the present inventors have conducted intensive studies to achieve the above object, and as a result, a 2- (2-methyladamantyl) -12′-adamantylmethane compound having a specific structure has not been published in the literature. It is a novel compound that has excellent heat resistance, water resistance, optical properties, etc., and that it can be efficiently produced by a specific process. Also, an alkoxycarbonyl group having 3 or more carbon atoms (carbon number Biadamantane having a specific structure having two or more alkoxy groups) is a novel compound that has not been published in the literature and has excellent heat resistance, water resistance, optical properties, etc., and excellent solubility in various solvents. Was found. The present invention has been completed based on such findings.
  • ⁇ 2 are each a hydrogen atom, a halogen atom, a hydrocarbyl group A hydroxyl group, a hydrocarbyloxy group, a carboxyl group or a hydrocarboxycarbonyl group, which may be the same or different.
  • R represents an alkyl group having 2 to 8 carbon atoms.
  • FIG. 1 is a ' ⁇ -NMR spectrum chart of the compound obtained in Example 1
  • FIG. 2 is a' 3 C-NMR spectrum chart of the compound obtained in Example 1)
  • FIG. 3 is an infrared analysis chart of the compound obtained in Example 1.
  • Figure 4 ' is t Figure 5 is .eta.
  • NMR spectrum chart of the compound obtained in Example 2' of the compound obtained in Example 2 is 3 C-NMR spectrum chart ( FIG. 6 is an infrared analysis chart of the compound obtained in Example 1.
  • the 2- (2-methyladamantyl) -1 2'-adamantyl methane compound of the present invention has the following general formula (I)
  • Y 1 and Y 2 each represent a hydrogen atom, a halogen atom, a hydrocarbyl group, a hydroxyl group, a hydrocarbyloxy group, a carboxy group or a hydrocarbylcarbonyl group.
  • preferred examples of the halogen atom include a chlorine atom, a bromine atom and an iodine atom.
  • Examples of the hydrocarbyl group include an alkyl group having 1 to 10 carbon atoms, an aryl group having 6 to 15 carbon atoms, and an aralkyl group having 7 to 15 carbon atoms.
  • the alkyl group having 1 to 10 carbon atoms may be linear, branched or cyclic, and examples thereof include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, n-butyl group, isobutyl group, sec-butyl group, tert-butyl group, various benzyl groups, various hexyl groups, various octyl groups, various decyl groups, cyclopentyl groups, cyclohexyl groups, methylcyclohexyl groups, etc.
  • the aryl group having 6 to 15 carbon atoms and the aralkyl group having 7 to 15 carbon atoms may have a substituent such as a lower alkyl group on the ring, and examples thereof include a phenyl group, a tolyl group, Xylyl, naphthyl, methylnaphthyl, benzyl, methylbenzyl, phenethyl, naphthylmethyl and the like.
  • hydrocarbyl group constituting the hydrocarbyloxy group and the hydrocarbyloxycarbonyl group examples include the same as those described above for the hydrocarbyl group.
  • Y 1 and Y 2 may be the same or different from each other.
  • 2- (2-methyladamantyl) -1′-adamantylmethane in which Y 1 and Y 2 are both hydrogen atoms and the general formula (I) In which at least one of Y 1 and Y 2 is a hydroxyl group and the remainder is a hydrogen atom (that is, both are hydroxyl groups, or one is a hydroxyl group and the remainder is a hydrogen atom).
  • Damantyl) — 1 ' a Damantimyl hydroxide is preferred.
  • the method for producing the 2- (2-methyladamantyl) -12'-adamantyl methane compound represented by the general formula (I) of the present invention is not particularly limited, but the method of the present invention shown below is provided. If it follows, it can manufacture efficiently.
  • 2-methyl-2-adamantanol (111) is dehydrated and dimerized in the presence of an acid catalyst to obtain a compound (IV), and then hydrogenated to give 2- (2-methyladamantyl)
  • 2- (2-methyladamantyl) One 2'-adamantylmethane (V) is obtained.
  • a solvent in the dehydration-dimerization reaction, the presence of a solvent is not essential, but a solvent can be used if necessary.
  • the solvent is not particularly limited as long as it is inert to the reaction and is capable of dissolving the raw materials and products, and examples thereof include aliphatic hydrocarbon compounds such as hexane, heptane, and octane. Aromatic hydrocarbon compounds such as benzene, toluene and xylene are preferably used.
  • the acid catalyst examples include mineral acids such as sulfuric acid and hydrochloric acid, as well as heteropoly acids, zeolites, and ion exchange resins. These acid catalysts are based on 2-methyl-_ 2 Adaman evening Nord raw materials usually used in the proportion of ⁇ 1 0 weight 0/0.
  • the raw material concentration in the reaction system is not particularly limited, but the catalyst concentration is preferably about 0.1 to 5% by weight.
  • the temperature in the dehydration-dimerization reaction is selected in the range of usually room temperature to 150 ° C, preferably 50 to 10 ° C.
  • the reaction time depends on the reaction temperature, type and amount of catalyst, etc. The time is usually 1 to 24 hours, preferably about 1 to 3 hours.
  • the compound (IV) thus dehydrated and dimerized is isolated according to a conventional method, and is subjected to the next hydrogenation reaction.
  • a solvent in this hydrogenation reaction, the presence of a solvent is not essential, but a solvent can be used if necessary.
  • the solvent is not particularly limited as long as it is inert to the reaction and is capable of dissolving the raw material and the product. Examples thereof include aliphatic hydrocarbon compounds such as hexane, heptane, and octane; Aromatic hydrocarbon compounds such as benzene, toluene and xylene are preferably used.
  • a known hydrogenation catalyst represented by, for example, a Pt catalyst, Pd / C, Ru / C, Raney Ni or the like is used as a catalyst. These hydrogenation catalysts are usually used in an amount of about 1 to 10% by weight based on the raw materials.
  • the raw material concentration in the reaction system is not particularly limited, but the hydrogenation catalyst concentration is preferably about 0.1 to 5% by weight.
  • the temperature in the hydrogenation reaction is selected in the range of usually room temperature to 250 ° C, preferably 100 to 200 ° C.
  • the hydrogen pressure is usually selected in the range of 0.5 to 5 MPa, preferably in the range of 2 to 3 MPa.
  • the reaction time depends on the reaction temperature, the hydrogen pressure, the type of the catalyst, and the like, and cannot be unconditionally determined, but is usually 1 to 1 hour, preferably about 1 to 6 hours.
  • X 1 and X 2 are halogen atom and the remainder is a hydrogen atom).
  • halogenation method various methods can be used depending on the type of halogen.
  • the case where the halogen is bromine will be described.
  • a solvent is not essential, but a solvent can be used if necessary.
  • a solvent for example, a polar solvent such as methylene chloride or carbon tetrachloride is preferably used.
  • a Lewis acid such as aluminum trihalide or boron tribromide can be used as a catalyst.
  • the temperature of the bromination reaction is usually from room temperature to about 60 ° C. A reaction time of about 1 to 10 hours is sufficient.
  • the product brominated in this manner is isolated according to a conventional method. When this product is used as a raw material and a bromine atom in a molecule is converted to another group, it can be used as a crude product without purification. Purified according to the method.
  • the desired 2- (2-methyladamantyl) -2′-adamantyl methane bromide [in the general formula (10, at least one of X ′ and X 2 is a bromine atom and the remaining Are hydrogen atoms, that is, both are bromine atoms, or one is a bromine atom and the other is a hydrogen atom).
  • 2_ (2-meth) represented by the general formula ( ⁇ ) Ladamantyl) Starting from 1'2'-adamantyl methane halide, converting at least one halogen atom into a hydrocarbyl, hydroxyl, hydrocarbyloxy, carboxyl or hydrocarbyloxycarbonyl group,
  • the 2- (2-methyladamantyl) -12'-adamantylmethane derivative of the present invention having the above-mentioned various groups in the molecule can be produced.
  • the bromide obtained as described above is preferable from the viewpoint of reactivity.
  • R, MgX, R'Li or R 'RLi R' is a hydrocarbyl group and X is a halogen atom
  • R' is a hydrocarbyl group and X is a halogen atom
  • a polar solvent such as tetrahydrofuran, 2- ( 2-methyl-adamantyl) 1 2'-adamantyl
  • 2- ( 2-methyl-adamantyl) 1 2'-adamantyl can introduce a hydrocarbyl group or hydrocarbyloxy group into methane
  • a hydrogen halide scavenger such as an organic base such as pyridine, triethylamine or dimethylformamide at a temperature of about 100 to 200 ° C for about 1 to 24 hours
  • a hydroxyl group can be introduced into 2— (2-methyladamantyl) -1 2′-adamantylmethane.
  • the hydroxyl obtained in the above (2) is used.
  • a compound having a carboxylic group is reacted with a carboxylating agent such as carbon monoxide and formic acid to carbonylate the hydroxyl group at the hydroxyl group to give 2- (2-methyladamantyl) -1 2'-adamantyl.
  • Carboxyl groups can be introduced into methane.
  • a solvent is not essential, but if necessary, a hydrocarbon solvent such as hexane can be used.
  • an R'OH R '
  • the esterification of the carboxyl group can introduce a hydrocarbyloxycarbonyl group into 2- (2-methyladamantyl) -1′-adamantylmethane.
  • a solvent is not essential, but an appropriate solvent can be used if necessary.
  • the compound of the above (3) may be treated with thionyl chloride, phosphorus pentachloride or the like to synthesize acid chloride, and then reacted with R'OLi.
  • the biadamantane derivative of the present invention has the following general formula (VI)
  • R represents an alkyl group having 2 to 8 carbon atoms (linear or branched alkyl group), specifically, an ethyl group, an ⁇ -propyl group, an isopropyl group, an ⁇ -butyl group, an isobutyl group , Sec-butyl, tert-butyl, n-amyl, isoamyl, n-hexyl, n-heptyl, n-octyl or isooctyl.
  • the two Rs in the general formula (VI) are usually the same, but may be different depending on the case.
  • the biadamantane derivative of the present invention is 3,3′-dialkoxycarbone-l-biadamantane represented by the general formula (VI), and specifically, 3,3′-diethoxycarbonyl_1, One viadamantane, 3, 3 'di ⁇ -propoxycarbone 1, one viadamantane, 3, 3' diisopropoxycarbone 2, 1, one viadamantane, 3, 3 '— di ⁇ -butoxycarbo Two-way 1 'one-viadamantane, 3, 3'-diisobutoxycarbone 1, 1, 1' one-viadamantane, 3, 3 'di-t-butoxycarbone two-one, one-viadamantane, 3, 3'- Diamiloxycarbone and one viadamantane.
  • VI 3,3′-dialkoxycarbone-l-biadamantane represented by the general formula (VI), and specifically, 3,3′-diethoxycarbonyl_1, One viadamantane, 3, 3 'di ⁇ -
  • the method for producing the biadamantane derivative of the present invention is not particularly limited.
  • Examples of the acid catalyst include mineral acids such as sulfuric acid and hydrochloric acid; organic acids such as p-toluenesulfonic acid; and Lewis acids such as boron fluoride ether.
  • Examples of reagents for converting (COOH) to acid halide (COX) include phosphoryl chloride, thionyl chloride, phosphorus pentachloride, and phosphorus trichloride.
  • the 3,3′-dicarboxy-1,1,1′-biadamantane represented by the formula (VII) used as a raw material here is biadamantane, 3,1,3′-biadamantane or 3,3′-dihydroxy It is synthesized by using 1,1'-biadamantane as a starting material and reacting it with formic acid in the presence of a strong acid such as fuming sulfuric acid, concentrated sulfuric acid or concentrated nitric acid, or in a carbon monoxide atmosphere.
  • a strong acid such as fuming sulfuric acid, concentrated sulfuric acid or concentrated nitric acid, or in a carbon monoxide atmosphere.
  • reaction solution was poured into 100 g of water, neutralized with an aqueous solution of sodium carbonate, and the product was extracted with n-heptane. The oil layer was washed with water. Thereafter, n-heptane was distilled off with a dry evaporator to obtain 29.9 g of a crude product. Next, the crude product was passed through a silica gel column, recrystallized, and dried. 6.2 g of solid A1 were obtained.
  • a 300 milliliter autoclave was charged with 15.0 g of the solid A obtained in (1) above, 3.0 g of 5% by weight Pd / C, and 150 milliliter of ⁇ -octane, and charged with 150 ml of hydrogen. It was pressurized to MPa and reacted at 20 ° C. for 5 hours.
  • Example 2 In a 100 milliliter four-necked flask equipped with a cooling tube and a dropping funnel, 6.0 g (20 millimoles) of the solid B obtained in Example 1 was charged, and the mixture was added dropwise while stirring the inside with a stirrer. 25 g of bromine was slowly dropped from the funnel. After completion of the dropwise addition, the mixture was heated to 60 ° C. in an oil bath and reacted for 4 hours.
  • the reaction solution was cooled, poured into a flask containing 100 g of ice and 50 milliliter of carbon tetrachloride, and excess bromine was treated with sodium hydrogen sulfite. After that, extraction with carbon tetrachloride, washing with water and evaporation of the solvent were performed to obtain 12.2 g of a crude bromide. Next, the crude bromide, 50 ml of pyridine and 18 ml of water were charged into a 100 ml autoclave and reacted at 150 ° C. for 6 hours. After completion of the reaction, sodium carbonate was added to the reaction solution to decompose pyridine monohydrobromide generated in the reaction.
  • Example 3 (1) Synthesis of 3,3, dimethoxycarbone 1'-biadamantane In Example 3, methanol was used in place of n-propanol, methanol was added to the reaction solution, and the filtrate was filtered. Except for concentrating and recrystallizing with methanol, the same procedure as in Example 3 was carried out to obtain 0.35 g, 98.5% purity of 3,3'-dimethoxycarbone and 1'-biadamantane. I got
  • the 2- (2-methyladamantyl) -adamantyl methane compound of the present invention is a novel asymmetric bisadamantane compound having an adamantane skeleton bonded through a methylene group, and has heat resistance and water resistance. It has excellent properties and optical properties, and is useful as a component of coating materials and optical materials. This can be efficiently produced by the method of the present invention.
  • 3,3′-dialkoxy force 1′-biadamantane a novel biadamantane derivative of the present invention, is excellent in heat resistance, water resistance, optical properties, etc., and is excellent in solubility in various solvents. It is something. Therefore, it can be used in a variety of applications, and can be widely used as optical materials such as optical disc substrates, optical fibers, lenses, and intermediates of organic chemicals.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

2-(2-Methyladamantyl)-2'-adamantylmethane compounds of the general formula (I) [wherein Y?1 and Y2¿ may be the same or different from each other and are each hydrogen, halogeno, hydrocarbyl, hydroxyl, hydrocarbyloxy, carboxyl, or hydrocarbyloxycarbonyl], and 3,3'-dialkoxycarbonyl-1,1'-biadamantane derivatives of the general formula (VI) [wherein R is alkyl having 2 to 8 carbon atoms]. The above novel bisadamantane compounds and the above novel biadamantane derivatives are excellent in heat resistance, water resistance and optical properties.

Description

明 細 書 新規 (ビス) ァダマンタン系化合物、 その製造方法及び新規ビアダマンタン誘導 体 技術分野  Description New (bis) adamantane-based compound, process for producing the same, and new biadamantane derivative technical field
本発明は、 新規な 2— ( 2—メチルァダマンチル) 一 2 ' —ァダマンチルメタ ン系化合物である新規 (ビス) ァダマンタン系化合物、 その製造方法及び 3, 3 , ージアルコキシカルボ二ルーし 1 ' —ビアダマンタンである新規ビアダマン タン誘導体に関する。 さらに詳しくは、 耐熱性、 耐水性及び光学特性などに優れ 、 コーティング材料や光学材料などの成分として有用な 2— ( 2—メチルァダマ ンチル) 一 2 ' —ァダマンチルメタン系化合物、 このものを効率よく製造する方 法、 及びビアダマンタン類の特性を保持しつつ、 各種溶剤に対する溶解性に優れ た新規ビアダマンタン誘導体に関するものである。 景技術  The present invention relates to a novel (bis) adamantane-based compound which is a novel 2- (2-methyladamantyl) -12'-adamantylmethane-based compound, a method for producing the same, and a method for producing 3,3, dialkoxycarbone. '—Relates to a new biadamantane derivative that is biadamantane. More specifically, a 2- (2-methyladamantyl) -12'-adamantyl methane compound, which has excellent heat resistance, water resistance and optical properties, and is useful as a component in coating materials and optical materials, etc. The present invention relates to a novel biadamantane derivative which is well-produced, and which has excellent solubility in various solvents while maintaining the properties of biadamantans. Landscape technology
従来から、 ァダマンタン類は非常に安定な炭素骨格を有すると共に、 特異な機 能を示すことから、 様々な用途に供せられ、 特にその光学特性や耐熱性から光デ イスク基盤、 光ファイバ一あるいはレンズなどに用いられている (特開平 9一 3 0 2 0 7 7号公報および特開平 6— 3 0 5 0 4 号公報など) 。  Conventionally, adamantanes have a very stable carbon skeleton and exhibit a unique function, so that they can be used for various applications.In particular, due to their optical characteristics and heat resistance, optical disk substrates, optical fibers, It is used for lenses and the like (Japanese Unexamined Patent Publication No. Hei 9-310207, Japanese Unexamined Patent Publication No. Hei 6-304504).
しかしながら、 上述のァダマンタン類は、 モノアダマンタン系化合物をモノマ —とするポリマーが主であり、 また、 ァダマンタン骨格が二つ以上結合した物質 及びその誘導体は知られているが、 ァダマンタン骨格がメチレン基を介して結合 した非対称のビスァダマン夕ン系化合物については、 ほとんど知られていないの が実状である。  However, the above-mentioned adamantane is mainly composed of a polymer having a monoadamantane compound as a monomer, and a substance having two or more adamantane skeletons and a derivative thereof are known, but the adamantane skeleton has a methylene group. As a matter of fact, little is known about asymmetric bis-adaman-based compounds linked via a bond.
また、 ァダマンタン骨格が二つ以上結合したビアダマンタン類は、 さらに高い 耐熱性や特異な機能が期待されている。 In addition, biadamantanes having two or more adamantane skeletons are more expensive. Heat resistance and unique functions are expected.
しかしながら、 従来から知られているビアダマンタン類、 特に 3 , 3 ' —ジメ トキシカルボ二ルーし 1 ' 一ビアダマンタン (米国特許第 3 3 4 2 8 8 0号明 細書) は、 溶解性に乏しく、 種々の用途展開を行う上で大きな制約となっていた  However, conventionally known biadamantans, especially 3,3'-dimethoxycarbone and 1'-biadamantane (U.S. Pat. No. 3,342,880) are poorly soluble, It was a major constraint in developing various applications
発明の開示 Disclosure of the invention
本発明は、 このような状況下で、 耐熱性、 耐水性及び光学特性などに優れる、 ァダマンタン骨格がメチレン基を介して結合した非対称の新規なビスァダマン夕 ン系化合物、 その製造方法及び耐熱性、 耐水性及び光学特性などに優れると共に 、 各種溶剤に対する溶解性に優れた新規なビアダマンタン類を提供することを目 的とするものである。  Under such circumstances, the present invention provides a novel asymmetric bisadamanone-based compound having an adamantane skeleton bonded via a methylene group, which is excellent in heat resistance, water resistance, optical properties, and the like; An object of the present invention is to provide a novel biadamantane which is excellent in water resistance and optical properties and is excellent in solubility in various solvents.
本発明者らは、 前記目的を達成するために鋭意研究を重ねた結果、 特定の構造 を有する 2— ( 2—メチルァダマンチル) 一 2 ' —ァダマンチルメタン系化合物 は文献未載の新規な化合物であって、 耐熱性、 耐水性及び光学特性などに優れる こと、 そして、 このものは特定の工程により、 効率よく製造しうること、 また、 炭素数 3以上のアルコキシカルボニル基 (炭素数 2以上のアルコキシ基) を有す る特定の構造のビアダマンタン類は文献未載の新規な化合物であつて、 耐熱性、 耐水性及び光学特性などに優れると共に、 各種溶剤に対する溶解性に優れること を見出した。 本発明は、 かかる知見に基づいて完成したものである。  The present inventors have conducted intensive studies to achieve the above object, and as a result, a 2- (2-methyladamantyl) -12′-adamantylmethane compound having a specific structure has not been published in the literature. It is a novel compound that has excellent heat resistance, water resistance, optical properties, etc., and that it can be efficiently produced by a specific process. Also, an alkoxycarbonyl group having 3 or more carbon atoms (carbon number Biadamantane having a specific structure having two or more alkoxy groups) is a novel compound that has not been published in the literature and has excellent heat resistance, water resistance, optical properties, etc., and excellent solubility in various solvents. Was found. The present invention has been completed based on such findings.
すなわち、 本発明は、  That is, the present invention
( 1 ) 一般式 ( I )
Figure imgf000004_0001
(1) General formula (I)
Figure imgf000004_0001
(式中、 及び Υ 2 は、 それぞれ水素原子、 ハロゲン原子、 ヒドロカルビル基 、 ヒドロキシル基、 ヒドロカルビルォキシ基、 カルボキシル基又はヒドロカルビ ルォキシカルボ二ル基を示し、 それらはたがいに同一でも異なっていてもよい。(Wherein, and Υ 2 are each a hydrogen atom, a halogen atom, a hydrocarbyl group A hydroxyl group, a hydrocarbyloxy group, a carboxyl group or a hydrocarboxycarbonyl group, which may be the same or different.
) で表される 2— ( 2—メチルァダマンチル) 一 2' —ァダマンチルメタン系化 合物、 )) 2-(2-methyladamantyl) 1 2 '-adamantyl methane compound,
( 2 ) 酸触媒の存在下、 2—メチル _ 2—ァダマンタノールを脱水二量化した のち、 水素添加する 2— ( 2—メチルァダマンチル) — 1' ーァダマンチルメタ ンの製造方法、  (2) Method for producing 2- (2-methyladamantyl) -1′-adamantyl methane after dehydrating and dimerizing 2-methyl-2-adamantanol in the presence of an acid catalyst, followed by hydrogenation ,
( 3 ) 2 - ( 2—メチルァダマンチル) — ーァダマンチルメタンをハロゲ ン化する、 一般式 (II)
Figure imgf000005_0001
(3) 2-(2-Methyladamantyl) — General formula (II) for halogenating adamantylmethane
Figure imgf000005_0001
(式中、 X1 及び X2 は、 少なくとも一方がハロゲン原子で、 残りが水素原子で ある。 ) で表される 2— ( 2—メチルァダマンチル) — 1' ーァダマンチルメ夕 ンハロゲン化物の製造方法、 及び (Wherein, at least one of X 1 and X 2 is a halogen atom and the remainder is a hydrogen atom.) A method for producing a 2- (2-methyladamantyl) -1′-adamantyl methyl halide , as well as
(4 ) 上記一般式 (Π) で表される 2— ( 2—メチルァダマンチル) 一 2' - ァダマンチルメタンハロゲン化物を原料とし、 その少なくとも一つのハロゲン原 子を、 ヒドロカルビル基、 ヒドロキシル基、 ヒドロカルビルォキシ基、 カルボキ シル基又はヒドロカルビルォキシカルボニル基に変換する 2— ( 2—メチルァダ マンチル) _ 2' —ァダマンチルメタン誘導体の製造方法、  (4) Starting from 2- (2-methyladamantyl) -1 2'-adamantyl methane halide represented by the above general formula (Π), at least one halogen atom is converted to a hydrocarbyl group, a hydroxyl group or a hydroxyl group. A 2-, (2-methyladamantyl) _2'-adamantyl methane derivative, which is converted into a hydrocarbyloxy group, a carboxyl group or a hydrocarboxycarbonyl group;
( 5 ) 一般式 (VI)  (5) General formula (VI)
Figure imgf000005_0002
Figure imgf000005_0002
(式中、 Rは炭素数 2〜 8のアルキル基を示す。 ) で表される新規ビアダマン夕 ン誘導体 (Wherein, R represents an alkyl group having 2 to 8 carbon atoms.) Derivatives
を提供するものである。 図面の簡単な説明 Is provided. BRIEF DESCRIPTION OF THE FIGURES
図 1は、 実施例 1で得られた化合物の 'Η— NMRスぺク トルチャートである ( 図 2は、 実施例 1で得られた化合物の'3 C— NMRスぺク トルチャートである ( 図 3は、 実施例 1で得られた化合物の赤外線分析チャートである。 FIG. 1 is a 'Η-NMR spectrum chart of the compound obtained in Example 1 ( FIG. 2 is a' 3 C-NMR spectrum chart of the compound obtained in Example 1) ( FIG. 3 is an infrared analysis chart of the compound obtained in Example 1.
図 4は、 実施例 2で得られた化合物の 'Η— NMRスぺク トルチャートである t 図 5は、 実施例 2で得られた化合物の'3 C— NMRスぺク トルチャートである ( 図 6は、 実施例 1で得られた化合物の赤外線分析チヤ一卜である。 発明を実施するための最良の形態 Figure 4 'is t Figure 5 is .eta. NMR spectrum chart of the compound obtained in Example 2' of the compound obtained in Example 2 is 3 C-NMR spectrum chart ( FIG. 6 is an infrared analysis chart of the compound obtained in Example 1. BEST MODE FOR CARRYING OUT THE INVENTION
本発明の 2— ( 2—メチルァダマンチル) 一 2' ァダマンチルメタン系化合 物は、 下記の一般式 ( I )
Figure imgf000006_0001
The 2- (2-methyladamantyl) -1 2'-adamantyl methane compound of the present invention has the following general formula (I)
Figure imgf000006_0001
で表される構造を有する文献未載の新規な化合物である。 This is a novel compound having a structure represented by the following, which has not been published in any literature.
上記一般式 ( I ) において、 Y1 及び Y2 は、 それぞれ水素原子、 ハロゲン原 子、 ヒドロカルビル基、 ヒドロキシル基、 ヒドロカルビルォキシ基、 カルボキシ ル基又はヒドロカルビルォキシカルボ二ル基を示す。 ここで、 ハロゲン原子とし ては、 塩素原子、 臭素原子、 ヨウ素原子が好ましく挙げられる。 In the above general formula (I), Y 1 and Y 2 each represent a hydrogen atom, a halogen atom, a hydrocarbyl group, a hydroxyl group, a hydrocarbyloxy group, a carboxy group or a hydrocarbylcarbonyl group. Here, preferred examples of the halogen atom include a chlorine atom, a bromine atom and an iodine atom.
ヒドロカルビル基としては、 例えば炭素数 1 ~ 1 0のアルキル基、 炭素数 6〜 1 5のァリール基及び炭素数 7〜 1 5のァラルキル基を挙げることができる。 炭 素数 1 ~ 1 0のアルキル基は、 直鎖状、 枝分かれ状、 環状のいずれであってもよ く、 その例としては、 メチル基、 ェチル基、 n—プロピル基、 イソプロピル基、 n—ブチル基、 ィソブチル基、 s e c—ブチル基、 t e r t—プチル基、 各種べ ンチル基、 各種へキシル基、 各種ォクチル基、 各種デシル基、 シクロペンチル基 、 シクロへキシル基、 メチルシクロへキシル基などが挙げられる。 炭素数 6〜 1 5のァリール基及び炭素数 7〜 1 5のァラルキル基は、 その環上に低級アルキル 基などの置換基を有していてもよく、 その例としてはフヱニル基、 トリル基、 キ シリル基、 ナフチル基、 メチルナフチル基、 ベンジル基、 メチルベンジル基、 フ エネチル基、 ナフチルメチル基などが挙げられる。 Examples of the hydrocarbyl group include an alkyl group having 1 to 10 carbon atoms, an aryl group having 6 to 15 carbon atoms, and an aralkyl group having 7 to 15 carbon atoms. The alkyl group having 1 to 10 carbon atoms may be linear, branched or cyclic, and examples thereof include a methyl group, an ethyl group, an n-propyl group, an isopropyl group, n-butyl group, isobutyl group, sec-butyl group, tert-butyl group, various benzyl groups, various hexyl groups, various octyl groups, various decyl groups, cyclopentyl groups, cyclohexyl groups, methylcyclohexyl groups, etc. No. The aryl group having 6 to 15 carbon atoms and the aralkyl group having 7 to 15 carbon atoms may have a substituent such as a lower alkyl group on the ring, and examples thereof include a phenyl group, a tolyl group, Xylyl, naphthyl, methylnaphthyl, benzyl, methylbenzyl, phenethyl, naphthylmethyl and the like.
また、 ヒドロカルビルォキシ基及びヒドロカルビルォキシカルボ二ル基を構成 するヒドロカルビル基としては、 前述のヒドロカルビル基と同じものを挙げるこ とができる。  Examples of the hydrocarbyl group constituting the hydrocarbyloxy group and the hydrocarbyloxycarbonyl group include the same as those described above for the hydrocarbyl group.
なお、 該 Y1 及び Y2 は、 たがいに同一であってもよく、 異なっていてもよい 前記一般式 ( I ) で表される 2— ( 2—メチルァダマンチル) 一 2' —ァダマ ンチルメタン系化合物の中で、 特に一般式 ( I ) において、 Y1 及び Y2 が共に 水素原子である 2— ( 2—メチルァダマンチル) —1' —ァダマンチルメタン、 及び一般式 ( I ) において、 Y1 及び Y2 のうちの少なくとも一方がヒドロキシ ル基で残りが水素原子 (つまり、 両方がヒドロキシル基、 あるいは一方がヒドロ キシル基で残りが水素原子) である 2— (2—メチルァダマンチル) — 1' —ァ ダマンチルメ夕ン水酸化物が好適である。 Y 1 and Y 2 may be the same or different from each other. 2- (2-methyladamantyl) -12′-adamantylmethane represented by the above general formula (I) Among the compounds, particularly, in the general formula (I), 2- (2-methyladamantyl) -1′-adamantylmethane in which Y 1 and Y 2 are both hydrogen atoms, and the general formula (I) In which at least one of Y 1 and Y 2 is a hydroxyl group and the remainder is a hydrogen atom (that is, both are hydroxyl groups, or one is a hydroxyl group and the remainder is a hydrogen atom). Damantyl) — 1 '—a Damantimyl hydroxide is preferred.
本発明の一般式 ( I ) で表される 2— (2—メチルァダマンチル) 一 2' —ァ ダマンチルメタン系化合物の製造方法としては特に制限はないが、 以下に示す本 発明の方法に従えば、 効率よく製造することができる。  The method for producing the 2- (2-methyladamantyl) -12'-adamantyl methane compound represented by the general formula (I) of the present invention is not particularly limited, but the method of the present invention shown below is provided. If it follows, it can manufacture efficiently.
まず、 一般式 ( I ) において、 Y' =Y2 =Ηの化合物である 2— ( 2—メチ ルァダマンチル) 一 2' —ァダマンチルメタンの製造方法について説明する。 この 2— ( 2—メチルァダマンチル) 一 ' —ァダマンチルメタンは、 本発明 の方法によれば、 下記の反応式 (a)
Figure imgf000008_0001
First, a method for producing 2- (2-methyl adamantyl) -12'-adamantyl methane, which is a compound of the general formula (I) where Y '= Y 2 = Η, will be described. According to the method of the present invention, the 2- (2-methyladamantyl) -1 -'- adamantyl methane can be obtained by the following reaction formula (a)
Figure imgf000008_0001
(IV)  (IV)
Figure imgf000008_0002
Figure imgf000008_0002
( V )  (V)
に従つて製造することができる。 It can be manufactured according to
すなわち、 酸触媒の存在下、 2—メチルー 2—ァダマンタノール (1 1 1)を脱水 二量化して化合物 (IV) を得たのち、 水素添加することにより、 2 — ( 2—メチ ルァダマンチル) 一 2 ' —ァダマンチルメタン (V ) が得られる。  That is, 2-methyl-2-adamantanol (111) is dehydrated and dimerized in the presence of an acid catalyst to obtain a compound (IV), and then hydrogenated to give 2- (2-methyladamantyl) One 2'-adamantylmethane (V) is obtained.
上記脱水二量化反応においては、 溶媒の存在は必須ではないが、 必要に応じ溶 媒を用いることができる。 この溶媒としては、 反応に対して不活性であって、 原 料及び生成物を溶解しうるものであればよく、特に制限されず、 例えばへキサン 、 ヘプタン、 オクタンなどの脂肪族炭化水素化合物や、 ベンゼン、 トルエン、 キ シレンなどの芳香族炭化水素化合物などが好ましく用いられる。  In the dehydration-dimerization reaction, the presence of a solvent is not essential, but a solvent can be used if necessary. The solvent is not particularly limited as long as it is inert to the reaction and is capable of dissolving the raw materials and products, and examples thereof include aliphatic hydrocarbon compounds such as hexane, heptane, and octane. Aromatic hydrocarbon compounds such as benzene, toluene and xylene are preferably used.
また、 酸触媒としては、 例えば硫酸、 塩酸などの鉱酸、 さらにはへテロポリ酸 、 ゼォライト、 イオン交換樹脂などを挙げることができる。 これらの酸触媒は、 原料の 2—メチル _ 2—ァダマン夕ノールに対して、 通常 〜 1 0重量0 /0の割合 で用いられる。 Examples of the acid catalyst include mineral acids such as sulfuric acid and hydrochloric acid, as well as heteropoly acids, zeolites, and ion exchange resins. These acid catalysts are based on 2-methyl-_ 2 Adaman evening Nord raw materials usually used in the proportion of ~ 1 0 weight 0/0.
反応系における原料濃度としては、 特に制限はないが、 該触媒濃度は 0 . 1 〜 5重量%程度が好ましい。  The raw material concentration in the reaction system is not particularly limited, but the catalyst concentration is preferably about 0.1 to 5% by weight.
この脱水二量化反応における温度は、 通常室温〜 1 5 0 °C、 好ましくは 5 0〜 1 0 o °cの範囲で選定される。 反応時間は、 反応温度、 触媒の種類や量などによ り左右され、 一概に定めることはできないが、 通常 1〜 2 4時間、 好ましくは 1 〜 3時間程度である。 The temperature in the dehydration-dimerization reaction is selected in the range of usually room temperature to 150 ° C, preferably 50 to 10 ° C. The reaction time depends on the reaction temperature, type and amount of catalyst, etc. The time is usually 1 to 24 hours, preferably about 1 to 3 hours.
このようにして、 脱水二量化された化合物 (IV) は、 常法に従って単離され、 次の水素添加反応に供される。  The compound (IV) thus dehydrated and dimerized is isolated according to a conventional method, and is subjected to the next hydrogenation reaction.
この水素添加反応においては、 溶媒の存在は必須ではないが、 必要に応じ溶媒 を用いることができる。 この溶媒としては、 反応に対して不活性であって、 原料 及び生成物を溶解しうるものであればよく、 特に制限されず、 例えばへキサン、 ヘプタン、 オクタンなどの脂肪族炭化水素化合物や、 ベンゼン、 トルエン、 キシ レンなどの芳香族炭化水素化合物などが好ましく用いられる。  In this hydrogenation reaction, the presence of a solvent is not essential, but a solvent can be used if necessary. The solvent is not particularly limited as long as it is inert to the reaction and is capable of dissolving the raw material and the product. Examples thereof include aliphatic hydrocarbon compounds such as hexane, heptane, and octane; Aromatic hydrocarbon compounds such as benzene, toluene and xylene are preferably used.
この水素添加反応においては、 触媒として、 例えば P t触媒、 P d/C、 Ru /C、 ラネ一 N iなどに代表される公知の水添触媒が用いられる。 これらの水添 触媒は、 原料に対して、 通常 1〜 1 0重量%程度使用される。  In this hydrogenation reaction, a known hydrogenation catalyst represented by, for example, a Pt catalyst, Pd / C, Ru / C, Raney Ni or the like is used as a catalyst. These hydrogenation catalysts are usually used in an amount of about 1 to 10% by weight based on the raw materials.
反応系における原料濃度としては、 特に制限はないが、 該水添触媒濃度は 0. 1〜 5重量%程度が好ましい。  The raw material concentration in the reaction system is not particularly limited, but the hydrogenation catalyst concentration is preferably about 0.1 to 5% by weight.
この水素添加反応における温度は、 通常室温〜 2 5 0 °C、 好ましくは 1 0 0〜 2 0 0 °Cの範囲で選定される。 また、 水素圧力は、 通常 0. 5〜 5MP a、 好ま しくは 2〜3 MP aの範囲で選定される。 さらに、 反応時間は、 反応温度や水素 圧力、 触媒の種類などにより左右され、 一概に定めることはできないが、 通常 1 〜 1 時間、 好ましくは 1 ~ 6時間程度である。  The temperature in the hydrogenation reaction is selected in the range of usually room temperature to 250 ° C, preferably 100 to 200 ° C. The hydrogen pressure is usually selected in the range of 0.5 to 5 MPa, preferably in the range of 2 to 3 MPa. Further, the reaction time depends on the reaction temperature, the hydrogen pressure, the type of the catalyst, and the like, and cannot be unconditionally determined, but is usually 1 to 1 hour, preferably about 1 to 6 hours.
このようにして水素添加された生成物は、 常法に従って単離し、 さらに精製処 理することにより、 目的の 2— ( 2—メチルァダマンチル) 一 2' —ァダマンチ ルメ夕ン (V) が得られる。  The product hydrogenated in this manner is isolated according to a conventional method, and further purified to give the desired 2- (2-methyladamantyl) -12'-adamantyl monomer (V). can get.
次に、 一般式 ( I ) において、 Y' 及び Y2 のうちの少なくとも一方がハロゲ ン原子で、 残りが水素原子 (つまり、 両方がハロゲン原子、 あるいは一方がハロ ゲン原子で残りが水素原子) である 2— ( 2—メチルァダマンチル) — 1' ーァ ダマンチルメタンハロゲン化物の製造方法について説明する。 この 2— ( 2—メチルァダマンチル) — 1' ーァダマンチルメタンハロゲン化 物は、 本発明の方法によれば、 下記の反応式 (b) Next, in the general formula (I), at least one of halogen atoms of Y 'and Y 2, the remaining being a hydrogen atom (i.e., both a halogen atom or one remaining is a hydrogen atom with halo gen atom,) The method for producing 2- (2-methyladamantyl) -1′-adamantyl methane halide will be described. According to the method of the present invention, the 2- (2-methyladamantyl) -1′-adamantyl methane halide is represented by the following reaction formula (b)
Figure imgf000010_0001
Figure imgf000010_0001
(式中、 X1 及び X2 は、 少なく とも一方がハロゲン原子で残りが水素原子であ る。 ) に従って製造することができる。 (Wherein, at least one of X 1 and X 2 is a halogen atom and the remainder is a hydrogen atom).
すなわち、 1— ( 2—メチルァダマンチル) — ' —ァダマンチルメタン (V ) をハロゲン化することにより、 2— ( 2—メチルァダマンチル) 一 2' —ァダ マンチルメタンハロゲン化物 (11) が得られる。  That is, by halogenating 1- (2-methyladamantyl) -'- adamantylmethane (V), 2- (2-methyladamantyl) 1-2'-adamantylmethane halide (11) is obtained.
ハロゲン化の方法としては、 ハロゲンの種類により、 様々な方法を用いること ができるが、 ここでは、 ハロゲンが臭素である場合について説明する。  As the halogenation method, various methods can be used depending on the type of halogen. Here, the case where the halogen is bromine will be described.
この臭素化反応においては、 溶媒は必須ではないが、 必要に応じ溶媒を用いる ことができる。 該溶媒としては、 例えば塩化メチレンや四塩化炭素などの極性溶 媒が好ましく用いられる。 また、 必要に応じ、 トリハロゲン化アルミニウムや三 臭化ホウ素などのルイス酸を触媒として用いることができる。 臭素化反応の温度 は、 通常室温〜 6 0°C程度である。 反応時間は 1〜 1 0時間程度で充分である。 このようにして臭素化された生成物は、 常法に従って単離する。 このものを原 料とし、 分子中の臭素原子を他の基に変換する場合には、 精製することなく、 粗 製品のまま使用することができるが、 製品とする場合には、 通常、 さらに常法に 従って精製処理される。 このようにして、 目的の 2— ( 2—メチルァダマンチル ) - 2' ーァダマンチルメタン臭化物 〔一般式 (10 において、 X' 及び X2 の うちの少なく とも一方が臭素原子で、 残りが水素原子であるもの、 即ち両方が臭 素原子、 あるいは一方が臭素原子で残りが水素原子であるもの) が得られる。 さらに、 本発明の方法によれば、 前記一般式 (Π) で表される 2 _ ( 2—メチ ルァダマンチル) 一 2' —ァダマンチルメタンハロゲン化物を原料とし、 その少 なくとも一つのハロゲン原子を、 ヒドロカルビル基、 ヒドロキシル基、 ヒドロカ ルビルォキシ基、 カルボキシル基又はヒドロカルビルォキシカルボニル基に変換 することにより、 分子内に上記各種の基を有する本発明の 2— (2—メチルァダ マンチル) 一 2' —ァダマンチルメタン誘導体を製造することができる。 In this bromination reaction, a solvent is not essential, but a solvent can be used if necessary. As the solvent, for example, a polar solvent such as methylene chloride or carbon tetrachloride is preferably used. If necessary, a Lewis acid such as aluminum trihalide or boron tribromide can be used as a catalyst. The temperature of the bromination reaction is usually from room temperature to about 60 ° C. A reaction time of about 1 to 10 hours is sufficient. The product brominated in this manner is isolated according to a conventional method. When this product is used as a raw material and a bromine atom in a molecule is converted to another group, it can be used as a crude product without purification. Purified according to the method. Thus, the desired 2- (2-methyladamantyl) -2′-adamantyl methane bromide [in the general formula (10, at least one of X ′ and X 2 is a bromine atom and the remaining Are hydrogen atoms, that is, both are bromine atoms, or one is a bromine atom and the other is a hydrogen atom). Furthermore, according to the method of the present invention, 2_ (2-meth) represented by the general formula (Π) Ladamantyl) Starting from 1'2'-adamantyl methane halide, converting at least one halogen atom into a hydrocarbyl, hydroxyl, hydrocarbyloxy, carboxyl or hydrocarbyloxycarbonyl group, The 2- (2-methyladamantyl) -12'-adamantylmethane derivative of the present invention having the above-mentioned various groups in the molecule can be produced.
この場合、 原料のハロゲン化物としては、 反応性の面から、 前述のようにして 得られた臭化物が好ましい。  In this case, as the raw material halide, the bromide obtained as described above is preferable from the viewpoint of reactivity.
次に、 前記一般式 (11) で表される化合物として、 2— ( 2—メチルァダマン チル) 一 2' —ァダマンチルメタン臭化物 (以下、 単に原料臭化物と称すること がある。 ) を用い、 その少なくとも一つの臭素原子を、 上記の種々の基に変換し 、 該基を導入する方法について説明する。  Next, as the compound represented by the general formula (11), 2- (2-methyladamantyl) -12′-adamantylmethane bromide (hereinafter sometimes simply referred to as a raw material bromide) is used. A method of converting at least one bromine atom into the above-described various groups and introducing the group will be described.
( 1 ) ヒドロカルビル基、 ヒドロカルビルォキシ基の導入  (1) Introduction of hydrocarbyl group and hydrocarbyloxy group
テトラヒドロフランなどの極性溶媒の存在下、 R, MgX、 R' L i又は R' 〇L i (R' はヒドロカルビル基、 Xはハロゲン原子を示す。 ) を原料臭化物に 反応させることにより、 2— ( 2—メチルァダマンチル) 一 2' —ァダマンチル メタンにヒドロカルビル基又はヒドロカルビルォキシ基を導入することができる  By reacting R, MgX, R'Li or R 'RLi (R' is a hydrocarbyl group and X is a halogen atom) with a raw bromide in the presence of a polar solvent such as tetrahydrofuran, 2- ( 2-methyl-adamantyl) 1 2'-adamantyl Can introduce a hydrocarbyl group or hydrocarbyloxy group into methane
( 2 ) ヒドロキシル基の導入 (2) Introduction of hydroxyl group
ピリジン, トリェチルァミンあるいはジメチルホルムアミ ドのような有機塩基 などのハロゲン化水素捕捉剤の存在下、 原料臭化物を、 1 0 0〜200 °C程度の 温度において、 1〜24時間程度加水分解処理することにより、 2— (2—メチ ルァダマンチル) 一 2' —ァダマンチルメタンにヒドロキシル基を導入すること ができる。  Hydrolysis of the raw bromide in the presence of a hydrogen halide scavenger such as an organic base such as pyridine, triethylamine or dimethylformamide at a temperature of about 100 to 200 ° C for about 1 to 24 hours Thus, a hydroxyl group can be introduced into 2— (2-methyladamantyl) -1 2′-adamantylmethane.
( 3 ) カルボキシル基の導入  (3) Introduction of carboxyl group
硫酸や塩酸などの鉱酸、 ヘテロポリ酸、 ゼォライ ト、 イオン交換樹脂などの酸 触媒及び Cu化合物などの助触媒の存在下、 上記 (2 ) で得られたヒドロキシル 基を有する化合物に、 一酸化炭素ゃギ酸などのカルボ二ル化剤を反応させ、 ヒド 口キシル基をカルボニル化することにより、 2— ( 2—メチルァダマンチル) 一 2' ーァダマンチルメタンにカルボキシル基を導入することができる。 In the presence of a mineral acid such as sulfuric acid or hydrochloric acid, a heteropoly acid, zeolite, an acid catalyst such as an ion exchange resin, and a cocatalyst such as a Cu compound, the hydroxyl obtained in the above (2) is used. A compound having a carboxylic group is reacted with a carboxylating agent such as carbon monoxide and formic acid to carbonylate the hydroxyl group at the hydroxyl group to give 2- (2-methyladamantyl) -1 2'-adamantyl. Carboxyl groups can be introduced into methane.
このカルボニル化反応においては、 溶媒は必須ではないが、 必要に応じ、 へキ サンなどの炭化水素系溶媒を用いることができる。  In this carbonylation reaction, a solvent is not essential, but if necessary, a hydrocarbon solvent such as hexane can be used.
( 4 ) ヒドロカルビルォキシカルボニル基の導入  (4) Introduction of hydrocarbyloxycarbonyl group
硫酸、 塩酸などの鉱酸、 ヘテロポリ酸、 ゼォライ ト、 イオン交換樹脂など酸触 媒の存在下、 上記 ( 3 ) で得られたカルボキシル基を有する化合物に R' OH ( R' 【まヒドロカルビル基を示す。 ) を反応させ、 カルボキシル基をエステル化す ることにより、 2— ( 2—メチルァダマンチル) — 1' ーァダマンチルメタンに ヒドロカルビルォキシカルボ二ル基を導入することができる。  In the presence of a mineral acid such as sulfuric acid or hydrochloric acid, a heteropoly acid, zeolite, an ion exchange resin or the like, an R'OH (R ' The esterification of the carboxyl group can introduce a hydrocarbyloxycarbonyl group into 2- (2-methyladamantyl) -1′-adamantylmethane.
このエステル化反応においては、 溶媒は必須ではないが、 必要に応じ、 適当な 溶媒を用いることができる。  In this esterification reaction, a solvent is not essential, but an appropriate solvent can be used if necessary.
上記 ( 3 ) の化合物を塩化チォニル, 五塩化リンなどで処理して酸クロライ ド を合成後、 R' OL i と反応させても良い。  The compound of the above (3) may be treated with thionyl chloride, phosphorus pentachloride or the like to synthesize acid chloride, and then reacted with R'OLi.
本発明のビアダマンタン誘導体は、 下記の一般式 (VI)  The biadamantane derivative of the present invention has the following general formula (VI)
Figure imgf000012_0001
Figure imgf000012_0001
で表される構造を有する文献未載の新規な化合物である。 This is a novel compound having a structure represented by the following, which has not been published in any literature.
上記一般式 (VI)において、 Rは炭素数 2〜 8のアルキル基 (直鎖あるいは分岐 アルキル基) 、 具体的には、 ェチル基, η—プロピル基, イソプロピル基, η— ブチル基, ィソブチル基, s e c—ブチル基, t e r t一ブチル基, n—ァミル 基, イソアミル基, n—へキシル基, n—ヘプチル基, n—ォクチル基又はイソ ォクチル基などを示す。 なお、 一般式(VI)における 2つの Rは、 通常は同一のものであるが、 場合によ つては異なっていてもよい。 In the above general formula (VI), R represents an alkyl group having 2 to 8 carbon atoms (linear or branched alkyl group), specifically, an ethyl group, an η-propyl group, an isopropyl group, an η-butyl group, an isobutyl group , Sec-butyl, tert-butyl, n-amyl, isoamyl, n-hexyl, n-heptyl, n-octyl or isooctyl. The two Rs in the general formula (VI) are usually the same, but may be different depending on the case.
本発明のビアダマンタン誘導体は、 一般式 (VI)で表される 3 , 3 ' —ジアルコ キシカルボ二ルー し 一ビアダマンタンであるが、 具体的には、 3 , 3 ' 一 ジエトキシカルボニル _ 1 , 一ビアダマンタン、 3, 3 ' ージ η—プロポキ シカルボ二ルー し 1, 一ビアダマンタン、 3 , 3 ' ージイソプロポキシカルボ 二ルー 1, 一ビアダマンタン、 3, 3 ' —ジ η—ブトキシカルボ二ルーし 1 ' 一ビアダマンタン、 3 , 3 ' —ジイソブトキシカルボ二ルー 1 , 1 ' 一ビア ダマンタン、 3, 3 ' ージ t—ブトキシカルボ二ルー 1, 一ビアダマンタン 、 3, 3 ' —ジアミロキシカルボ二ルー し 一ビアダマンタンなどを挙げる ことができる。  The biadamantane derivative of the present invention is 3,3′-dialkoxycarbone-l-biadamantane represented by the general formula (VI), and specifically, 3,3′-diethoxycarbonyl_1, One viadamantane, 3, 3 'di η-propoxycarbone 1, one viadamantane, 3, 3' diisopropoxycarbone 2, 1, one viadamantane, 3, 3 '— di η-butoxycarbo Two-way 1 'one-viadamantane, 3, 3'-diisobutoxycarbone 1, 1, 1' one-viadamantane, 3, 3 'di-t-butoxycarbone two-one, one-viadamantane, 3, 3'- Diamiloxycarbone and one viadamantane.
本発明のビアダマンタン誘導体の製造方法としては特に制限はないが、 例えば 式 (VI I)  The method for producing the biadamantane derivative of the present invention is not particularly limited.
Figure imgf000013_0001
Figure imgf000013_0001
で表される 3, 3 ' ージカルボキシー 1, 一ビアダマンタンと一般式 R〇H (式中、 Rは前記と同じ。 ) で表されるアルコールとを酸触媒の存在下でエステ ル化反応させる方法、 又は上記式 (VI I)の 3, 3 ' ージカルボキシ—し 一 ビアダマンタンの代わりに、 そのカルボキシル基を酸ハライ ドに変えた式 (VI Π) A esterification reaction of 3,3'-dicarboxy-1,1-biadamantane represented by the formula and an alcohol represented by the general formula R〇H (where R is the same as described above) in the presence of an acid catalyst Or the formula (VIVI) in which the carboxyl group is changed to an acid halide in place of 3,3'-dicarboxy-biadamantane of the above formula (VI I)
Figure imgf000013_0002
Figure imgf000013_0002
(式中、 Xはハロゲン原子を示す。 ) で表される 3, 3 ' —ジハロゲノカルボ二 ルー し じ 一ビアダマンタンと上記一般式 R OHで表されるアルコールとを反 応させる方法などがある。 (Wherein, X represents a halogen atom.) 3, 3'-dihalogenocarbon There is a method of reacting viadamantane with an alcohol represented by the above general formula ROH.
ここで酸触媒としては、 例えば硫酸や塩酸等の鉱酸、 p—トルエンスルホン酸 等の有機酸、 さらにはフッ化ホウ素エーテラ一ト等のルイス酸などを挙げること ができ、 また上述のカルボキシル基 (COOH) を酸ハライ ド (COX) に変換 する試薬としては、 塩化ホスホリル, 塩化チォニル, 五塩化リン, 三塩化リンな どを挙げることができる。  Examples of the acid catalyst include mineral acids such as sulfuric acid and hydrochloric acid; organic acids such as p-toluenesulfonic acid; and Lewis acids such as boron fluoride ether. Examples of reagents for converting (COOH) to acid halide (COX) include phosphoryl chloride, thionyl chloride, phosphorus pentachloride, and phosphorus trichloride.
なお、 ここで原料として用いる式 (VII)で表される 3, 3 ' ージカルボキシー 1 , 1 ' 一ビアダマンタンは、 ビアダマンタン、 し 一ジブ口モー 3, 3 ' —ビアダマンタンあるいは 3, 3 ' ージヒドロキシー 1, 1 ' 一ビアダマンタン を出発原料として、 これを発煙硫酸、 濃硫酸、 濃硝酸等の強酸の存在下でギ酸を 添加して反応させることにより、 あるいは一酸化炭素雰囲気下で合成される。 次に、 本発明を実施例により、 さらに詳細に説明するが、 本発明は、 これらの 例によってなんら限定されるものではない。  The 3,3′-dicarboxy-1,1,1′-biadamantane represented by the formula (VII) used as a raw material here is biadamantane, 3,1,3′-biadamantane or 3,3′-dihydroxy It is synthesized by using 1,1'-biadamantane as a starting material and reacting it with formic acid in the presence of a strong acid such as fuming sulfuric acid, concentrated sulfuric acid or concentrated nitric acid, or in a carbon monoxide atmosphere. Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.
実施例 1 Example 1
( 1 ) 2—メチルー 2—ァダマンタノールの脱水二量化  (1) Dehydration dimerization of 2-methyl-2-adamantanol
撹拌機、 冷却管、 ディーンスタークトラップを備えた 2 0 0ミ リ リツ トルの四 つ口フラスコに、 2—メチルー 1—ァダマンタノ一ル 4 1. 5 g ( 2 50ミ リモ ル) 、 硫酸 5. 0 g及び n—ヘプタン 1 20ミ リ リツ トルを仕込み、 オイルバス 中で加熱して、 溶媒を還流させ、 脱水しながら 4時間反応させた。  In a 200-milliliter four-necked flask equipped with a stirrer, condenser, and Dean-Stark trap, 2-methyl-1-adamantanol 41.5 g (250 millimoles), sulfuric acid 5. 0 g and 120 milliliters of n-heptane were charged and heated in an oil bath to reflux the solvent and react for 4 hours while dehydrating.
反応終了後、 反応液を水 1 00 g中に注ぎ、 炭酸ナトリウム水溶液で中和処理 したのち、 生成物を n—ヘプタンで抽出し、 次いで油層を水で洗浄した。 その後 、 n—ヘプタンを口一タリ一エバポレータで留去し、 粗生成物 2 9. 9 gを得た 次に、 この粗生成物をシリカゲルカラムに通じたのち、 再結晶し、 乾燥させて 固体 A 1 6. 2 gを得た。 After the completion of the reaction, the reaction solution was poured into 100 g of water, neutralized with an aqueous solution of sodium carbonate, and the product was extracted with n-heptane. The oil layer was washed with water. Thereafter, n-heptane was distilled off with a dry evaporator to obtain 29.9 g of a crude product. Next, the crude product was passed through a silica gel column, recrystallized, and dried. 6.2 g of solid A1 were obtained.
( 2 ) 水素添加  (2) Hydrogenation
3 0 0ミリリッ トルオー卜クレーブに上記 ( 1 ) で得た固体 A 1 5. 0 g、 5 重量%P d/C 3. 0 g及び η—才クタン 1 5 0ミリリツ トルを仕込み、 水素で 3 MP aに加圧し、 2 0 Οΐで 5時間反応させた。  A 300 milliliter autoclave was charged with 15.0 g of the solid A obtained in (1) above, 3.0 g of 5% by weight Pd / C, and 150 milliliter of η-octane, and charged with 150 ml of hydrogen. It was pressurized to MPa and reacted at 20 ° C. for 5 hours.
反応終了後、 触媒をろ別した反応液から、 溶媒を口一タリーエバポレータで留 去し、 粗生成物 1 5. 0 gを得た。 この粗生成物を再結晶し、 乾燥させて固体 B 1 1. 2 gを得た。  After the completion of the reaction, the solvent was distilled off from the reaction solution from which the catalyst had been filtered off by means of a tally evaporator to obtain 15.0 g of a crude product. The crude product was recrystallized and dried to obtain 11.2 g of solid B.
( 3) 固体 Bの同定  (3) Identification of solid B
上記 (2) で得られた固体 Bについて、各種の分析を行った。 分析結果は以下 のとおりである。  Various analyzes were performed on the solid B obtained in the above (2). The analysis results are as follows.
(ィ) ガスクロマトグラフィによる質量分析 (C I法)  (A) Mass spectrometry by gas chromatography (CI method)
分子イオン (M— 1 ) : 2 9 7  Molecular ion (M-1): 2 9 7
(口) ガスクロマトグラフィによる質量分析 (E I法)  (Mouth) Mass spectrometry by gas chromatography (EI method)
m/e (スぺク トル強度 (%) ) : 1 4 9 ( 1 00 ) , 1 07 ( 2 1. 7 5 ) , 9 3 ( 3 9. 2 5 ) , 7 9 ( 5 5. 2 1 )  m / e (spectral strength (%)): 149 (100), 107 (21.75), 93 (39.25), 79 (55.21) )
(ハ) 重クロ口ホルムを溶媒として測定したプロトン核磁気共鳴 ( — NM R) 分析値 (図 1参照)  (C) Proton nuclear magnetic resonance (—NMR) analysis values measured using double-mouthed form as a solvent (see Figure 1)
δ ( Ή/ρ pm) : 0. 90 7, 1. 0 1 8, 1. 29 2, 1. 4 50 , 1 . 5 7 3 , 1. 6 9 3 , 1. 74 6, 1. 804 , 1. 9 5 7, 2. 1 0 7 δ (Ή / ρ pm): 0.907, 1.01 8, 1.29 2, 1.450, 1.573, 1.693, 1.746, 1.804, 1. 9 5 7, 2. 1 0 7
(二) 重クロ口ホルムを溶媒として測定した同位体炭素核磁気共鳴 (13C— N MR) 分析値 (図 2参照) (2) Isotopic carbon nuclear magnetic resonance ( 13 C—N MR) analysis using double-mouthed form as a solvent (see Figure 2)
δ (13C/p pm) : 2 3. 2 7, 2 7. 88, 2 7. 9 5, 2 8. 1 2 , 2 8. 4 1 , 3 2. 3 3 , 3 3. 4 7, 3 3. 5 5, 34. 5 8, 36. 2 7, 3 8. 3 7, 38. 76, 3 9. 5 0, 3 9. 6 5, 3 9. 9 8, 4 2. 2 0δ ( 13 C / p pm): 23.27, 27.88, 27.95, 28.12, 28.41, 32.33, 33.47, 3 3.55, 34.5 8, 36.27, 38.37, 38.76, 39.50, 39.65, 39.98, 42.20
(ホ) 赤外線分析 (フーリエ変換赤外線吸収スぺク トル分析 (FT— I R) 、 拡散反射法) (図 3参照) (E) Infrared analysis (Fourier transform infrared absorption spectrum analysis (FT-IR), Diffuse reflection method) (See Fig. 3)
吸収 (cm— ') : 2994. 4, 2902. 4, 2848. 8 (CH3 , CH 2 , CH) ; 1 44 9. 1 , 1 377. 4, 1 3 52. 0 (CH3 , CH2 , C H) Absorption (cm- '): 2994. 4, 2902. 4, 2848. 8 (CH 3, CH 2, CH); 1 44 9. 1, 1 377. 4, 1 3 52. 0 (CH 3, CH 2 , CH)
これらの分析結果から、 固体 Bは、 下記の式
Figure imgf000016_0001
From these analysis results, solid B
Figure imgf000016_0001
で表される 2— ( 2—メチルァダマンチル) —2' ーァダマンチルメタンである ことが確認された。 It was confirmed to be 2— (2-methyladamantyl) —2′-adamantylmethane represented by
実施例 2 Example 2
( 1 ) 臭素化、 加水分解  (1) Bromination, hydrolysis
冷却管、 滴下ロートを備えた 1 00ミリリツ トルの四つ口フラスコに、実施例 1で得られた固体 B 6. 0 g (20ミ リモル) を仕込み、 スターラーで内部を撹 拌しながら、 滴下ロートより臭素 2 5 gをゆつく り滴下した。 滴下終了後、 オイ ルバスにて 60 °Cに加熱して 4時間反応させた。  In a 100 milliliter four-necked flask equipped with a cooling tube and a dropping funnel, 6.0 g (20 millimoles) of the solid B obtained in Example 1 was charged, and the mixture was added dropwise while stirring the inside with a stirrer. 25 g of bromine was slowly dropped from the funnel. After completion of the dropwise addition, the mixture was heated to 60 ° C. in an oil bath and reacted for 4 hours.
反応終了後、 反応液を冷却したのち、 氷 1 00 g、 四塩化炭素 50ミリリット ルの入ったフラスコに注ぎ、 過剰の臭素を亜硫酸水素ナ卜リゥムで処理した。 そ の後、 四塩化炭素で抽出し、 水洗、 溶媒留去して粗臭素化物 1 2. 2 gを得た。 次に、 1 00ミリ リットルオートクレーブに、 上記の粗臭素化物、 ピリジン 5 0ミリ リットル及び水 1 8ミリリッ トルを仕込み、 1 50 °Cで 6時間反応させた 。 反応終了後、 反応液に炭酸ナトリウムを加え、 反応で生成したピリジン一臭化 水素塩を分解させた。 次いで、 固体をろ別したのち、 ピリジン及び水を留去した 後、 トルエンを加えて留去し、 最後に水を加えて留去して粗生成物を得た。 次に、 この粗生成物をシリカゲルカラムに通じ、 溶媒を留去、 乾燥させて固体 C 4. 1 gを得た。 (2 ) 固体 Cの同定 After the reaction was completed, the reaction solution was cooled, poured into a flask containing 100 g of ice and 50 milliliter of carbon tetrachloride, and excess bromine was treated with sodium hydrogen sulfite. After that, extraction with carbon tetrachloride, washing with water and evaporation of the solvent were performed to obtain 12.2 g of a crude bromide. Next, the crude bromide, 50 ml of pyridine and 18 ml of water were charged into a 100 ml autoclave and reacted at 150 ° C. for 6 hours. After completion of the reaction, sodium carbonate was added to the reaction solution to decompose pyridine monohydrobromide generated in the reaction. Then, after the solid was filtered off, pyridine and water were distilled off, then toluene was added and distilled off, and finally water was added and distilled off to obtain a crude product. Next, this crude product was passed through a silica gel column, the solvent was distilled off, and the residue was dried to obtain 4.1 g of solid C. (2) Identification of solid C
上記 ( 1 ) で得られた固体 Cについて、 各種の分析を行った。 分析結果は以下 のとおりである。  Various analyzes were performed on the solid C obtained in (1) above. The analysis results are as follows.
(ィ) ガスクロマトグラフィによる質量分析 (C I法)  (A) Mass spectrometry by gas chromatography (CI method)
分子イオン (M— 1 ) : 3 1 3  Molecular ion (M— 1): 3 1 3
(口) ガスクロマトグラフィによる質量分析 (E I法)  (Mouth) Mass spectrometry by gas chromatography (EI method)
m/e (スぺク トル強度 ( ) ) : 3 1 2 ( 2 7. 3 1 ) , 1 6 5 ( 1 0 0 ) , 9 5 (8 1. 4 3 ) , 7 9 (2 5. 1 1 ) , 4 1 ( 28. 9 2)  m / e (spectral strength ()): 312 (27.31), 165 (100), 95 (81.43), 79 (25.1 1), 4 1 (28.9.2)
(ハ) 重クロ口ホルムを溶媒として測定した 1H— NMR分析値 (図 4参照) δ ( Ή/ρ pm) : 0. 94 6, 0. 9 7 6 , 1. 3 74, 1. 3 9 9 , 1 . 5 80 , 1. 6 6 1 , 1. 7 1 7, 1. 79 9, 1. 9 9 4 , 8. 80 (OH , 1 Η) (C) 1 H-NMR analysis value measured with double-mouthed form as a solvent (see Fig. 4) δ (Ή / ρ pm): 0.946, 0.976, 1.374, 1.3 9 9, 1.5 80, 1.66 1, 1.17 17, 1.79 9, 1.994, 8.80 (OH, 1 1)
8. 80 p pmは D2 0添加で消失 8.80 ppm disappears by adding D 20
(二) 重クロ口ホルムを溶媒として測定した'3 C— NMR分析値 (図 5参照) δ (13C/p pm) : ピークが多数あるため、 表示しない。 (2) ' 3 C-NMR analysis value measured using double-mouthed form as a solvent (see Fig. 5) δ ( 13 C / p pm): Not displayed because there are many peaks.
(ホ) 赤外線分析 (FT— I R, 拡散反射法) (図 6参照)  (E) Infrared analysis (FT-IR, diffuse reflection method) (See Fig. 6)
吸収 (cm—リ : 33 7 0. 8 (水酸基) 、 2 9 1 2. 8, 2 8 54. 2, 1 4 5 1. 5, 1 3 5 1. 8 (CH3 , CH2 , CH) Absorption (cm- Li: 33 7 0.8 (hydroxyl), 2 9 1 2. 8, 2 8 54. 2, 1 4 5 1. 5, 1 3 5 1. 8 (CH 3, CH 2, CH)
これらの分析結果から、 固体 Cは、 下記の式  From these analysis results, solid C
Figure imgf000017_0001
Figure imgf000017_0001
で表される 2— ( 2—メチルァダマンチル) 一 2' —ァダマンチルメタン水酸化 物の異性体混合物であると推定される。 It is presumed to be a mixture of isomers of 2- (2-methyladamantyl) -1 2'-adamantyl methane hydroxide represented by
実施例 3 ( 1 ) 3, 3 ' ージ n—プロポキシカルボ二ルーし 1 ' —ビアダマンタンの合 成 Example 3 (1) Synthesis of 3, 3'-n-propoxycarbone 1'-biadamantane
3 , 3 ' ージヒドロキシ一 し じ 一ビアダマンタン 0. 5 g ( 1. 6 5ミ リ モル) を濃硫酸 5ミ リリッ トルに溶解させ、 20°Cでギ酸 1ミ リ リッ トルをゆつ く り滴下した。 その後、 さらに 2時間攪拌した。 反応液を氷に注ぎ、 析出物をろ 取し、 それを水酸化ナトリウム水溶液に溶解させた後、 ろ過して不溶分を除いた 。 再度、 ろ液を塩酸で強酸性としてカルボン酸を析出させ、 それをろ取し、 洗液 が中性になるまで水洗、 その後メタノール洗浄を行い、 さらに真空乾燥した。 上記で得られた 3, 3 ' ージカルボキシ一し 一ビアダマンタンに塩化チ ォニル 1 0ミリ リツ トルを添加し、 3時間還流して均一溶液とした後、 過剰の塩 化チォニルを減圧下で留去し、 そこへ脱水処理した n—プロパノール 1 0ミ リ リ ッ トルを添加し、 1時間還流した。 その後、 反応液にメタノールを加えてろ過し 、 ろ液を濃縮し、 さらにへキサンを加えて不溶分をろ過した後、 濃縮し、 さらに アセトンを加えて不溶分をろ過した後、 濃縮した。 得られた生成物の収量は 0. 6 gであり、 ガスクロマトグラフィーによる純度は 9 9. 7%であった。  Dissolve 0.5 g (1.65 millimoles) of 3,3'-dihydroxy-dihydroxy-1-biadamantane in 5 milliliters of concentrated sulfuric acid and slowly add 1 milliliter of formic acid at 20 ° C. It was dropped. Thereafter, the mixture was further stirred for 2 hours. The reaction solution was poured into ice, the precipitate was collected by filtration, dissolved in an aqueous sodium hydroxide solution, and filtered to remove insoluble components. The filtrate was again made strongly acidic with hydrochloric acid to precipitate a carboxylic acid, which was collected by filtration, washed with water until the washing solution became neutral, then washed with methanol, and further dried under vacuum. To the 3,3'-dicarboxy-one-viadamantane obtained above, add 10 milliliters of thionyl chloride, reflux for 3 hours to form a homogeneous solution, and then distill off excess thionyl chloride under reduced pressure. Then, 10 milliliters of dehydrated n-propanol was added thereto, and the mixture was refluxed for 1 hour. Thereafter, methanol was added to the reaction solution, followed by filtration. The filtrate was concentrated, hexane was further added, and the insoluble matter was filtered. The mixture was concentrated, acetone was added thereto, and the insoluble matter was filtered, followed by concentration. The yield of the obtained product was 0.6 g, and the purity by gas chromatography was 99.7%.
また、 この生成物について、 下記の如く分析を行った。 その結果は、 次の通り である。  The product was analyzed as follows. The results are as follows.
①ガスクロマトグラフィーによる質量分析 (C I法)  ① Mass spectrometry by gas chromatography (CI method)
分子イオン (M— 1 ) : 4 4 3  Molecular ion (M-1): 4 4 3
②ガスクロマトグラフィーによる質量分析 (E I法)  ② Mass spectrometry by gas chromatography (EI method)
m/e (スぺクトル強度 (%) ) : 44 2 ( 1 0. 2 1 ) , 3 5 5 ( 1 8. 4 0 ) , 22 1 ( 1 00 ) , 1 7 9 ( 4 8. 3 1 ) , 1 3 3 ( 4 1. 5 3 ) m / e (spectral strength (%)): 442 (10.2), 355 (18.40), 221 (100), 179 (48.31) ), 1 3 3 (4 1.5 3)
③プロトン核磁気共鳴分析 Η— NMR) (溶媒:重クロ口ホルム) (3) Proton nuclear magnetic resonance analysis (II—NMR) (solvent: double-mouthed form)
δ CH/p pm) : 0. 86 9 (t , 6 H) , 1. 4〜し 90 (m, 2 8 H) , 2. 0 2 5 (m, 4 H) , 3. 94 3 ( t, 4 H)  δ CH / p pm): 0.869 (t, 6 H), 1.4 to 90 (m, 28 H), 2.0 25 (m, 4 H), 3.943 (t , 4H)
④同位体炭素核磁気共鳴分析 ( 13 C— N M R ) (溶媒:重クロ口ホルム) 513C/p pm) : 1 0. 34 1 , 2 2. 0 3 8, 28. 6 0 7, 3 4. 3 8 5, 3 6. 9 0 7, 36. 9 4 9, 3 8. 6 7 1 , 4 1. 7 1 3 , 6 5. 6 2 5 , 1 78. 2 1 0 ④ Isotopic carbon nuclear magnetic resonance analysis ( 13 C-NMR) (solvent: heavy-mouthed form) 5 13 C / p pm): 1 0.34 1, 2 2. 0 3 8, 28. 6 0 7, 3 4. 3 85, 3 6.90, 36. 9 49, 3 8. 6 7 1, 4 1.71 3, 6 5.6.2 5, 1 78.2 1 0
⑤フ一リエ変換赤外線吸収分析 (FT— I R, 拡散反射法)  一 Fourier transform infrared absorption analysis (FT-IR, diffuse reflection method)
吸収 (cm— ') : 1 726. 6カルボニル化合物 (エステル)  Absorption (cm— '): 1 726.6 Carbonyl compound (ester)
上記分析の結果、 得られた生成物は下式 (IX) で表される 3, 3' —ジ n—プ 口ポキシカルボ二ルー 1 , 一ビアダマンタンであることが同定された。  As a result of the above analysis, the obtained product was identified to be 3,3'-di-n-open-mouthed oxycarbone-1,1-biadamantane represented by the following formula (IX).
Figure imgf000019_0001
Figure imgf000019_0001
(2) 3, 3, ージ n—プロポキシカルボ二ルー し 一ビアダマンタンの溶 解性  (2) Solubility of 3,3, di-n-propoxycarbone-one viadamantane
上記 ( 1 ) で得られた 3, 3, —ジ n—プロポキシカルボ二ルー 1, 1 ' —ビ ァダマンタン 0. 5 gを、 1一ヘプ夕ノン 1 ミリ リッ トル、 2—へキサノン 1 ミ リリッ トル、 乳酸メチル 1 ミリ リッ トル、 乳酸ェチル 1 ミリ リッ トル、 ェチレン グリコールメチルェ一テルアセテート 1 ミ リ リツ トル、 又はプロピレングリコ一 ルメチルェ一テルアセテート 1 ミ リリツ トルに添加したところ、 いずれも容易に 溶解した。  0.5 g of 3,3, -di-n-propoxycarbone 1,1'-biadamantane obtained in the above (1) was mixed with 1 milliliter of 1-heptanone and 1 milliliter of 2-hexanone. Toluene, 1 milliliter of methyl lactate, 1 milliliter of ethyl lactate, 1 milliliter of ethylene glycol methyl ether acetate, or 1 milliliter of propylene glycol methyl acetate, all of which were easily added. Dissolved.
比較例 1 Comparative Example 1
( 1 ) 3 , 3, ージメ トキシカルボ二ルーし 1 ' —ビアダマンタンの合成 実施例 3において、 n—プロパノールの代わりにメタノールを使用し、 反応液 にメタノ一ルを加えてろ過し、 ろ液を濃縮してメタノールにより再結晶した以外 は、 実施例 3と同様の操作を行って、 収量 0. 3 5 g、 純度 98. 5%の 3, 3 ' —ジメ トキシカルボ二ルーし 1 ' —ビアダマンタンを得た。  (1) Synthesis of 3,3, dimethoxycarbone 1'-biadamantane In Example 3, methanol was used in place of n-propanol, methanol was added to the reaction solution, and the filtrate was filtered. Except for concentrating and recrystallizing with methanol, the same procedure as in Example 3 was carried out to obtain 0.35 g, 98.5% purity of 3,3'-dimethoxycarbone and 1'-biadamantane. I got
(2) 3 , 3' —ジメ トキシカルボ二ルー 1 , 1, 一ビアダマンタンの溶解性 上記 ( 1 ) で得られた 3 , 3 ' —ジメ トキシカルボ二ルー 1, 1 ' —ビアダマ ンタン 0 . 1 gを、 2—へキサノン 1 ミ リ リ ッ トル、 乳酸メチル 1 ミ リ リッ トル 、 乳酸ェチル 1 ミ リ リッ トル、 エチレングリコールメチルエーテルァセテ一ト 1 ミ リ リッ トル、 又はプロピレングリコ一ルメチルェ一テルアセテート 1 ミリリッ トルに添加したところ、 いずれも殆ど溶解しなかった。 産業上の利用可能性 (2) Solubility of 3,3'-dimethoxycarbone 1,1,1-biadamantane 0.1 g of 3,3'-dimethoxycarbone 1,1'-biadamantane obtained in (1) above, 1-milliliter of 2-hexanone, 1-milliliter of methyl lactate, and lactic acid When added to 1 milliliter of ethylene glycol, 1 milliliter of ethylene glycol methyl ether acetate, or 1 milliliter of propylene glycol methyl ether acetate, none of them was dissolved. Industrial applicability
本発明の 2— ( 2—メチルァダマンチル) — ーァダマンチルメタン系化合 物は、 ァダマンタン骨格がメチレン基を介して結合した非対称の新規なビスァダ マンタン系化合物であって、 耐熱性、 耐水性及び光学特性などに優れ、 コーティ ング材料や光学材料などの成分として有用である。 このものは、 本発明の方法に より、 効率よく製造することができる。  The 2- (2-methyladamantyl) -adamantyl methane compound of the present invention is a novel asymmetric bisadamantane compound having an adamantane skeleton bonded through a methylene group, and has heat resistance and water resistance. It has excellent properties and optical properties, and is useful as a component of coating materials and optical materials. This can be efficiently produced by the method of the present invention.
また、 本発明の新規なビアダマンタン誘導体である 3 , 3 ' ージアルコキシ力 ルポ二ルーし 1 ' 一ビアダマンタンは、 耐熱性、 耐水性及び光学特性などに優 れる共に、 各種溶剤に対する溶解性に優れたものである。 そのため、 多様な用途 展開が可能であり、 例えば光ディスク基盤、 光ファイバ一、 レンズ等の光学材料 、 さらには有機薬品の中間体などとしても広く利用することができる。  In addition, 3,3′-dialkoxy force 1′-biadamantane, a novel biadamantane derivative of the present invention, is excellent in heat resistance, water resistance, optical properties, etc., and is excellent in solubility in various solvents. It is something. Therefore, it can be used in a variety of applications, and can be widely used as optical materials such as optical disc substrates, optical fibers, lenses, and intermediates of organic chemicals.

Claims

請求の範囲 一般式 ( I )
Figure imgf000021_0001
Claims General formula (I)
Figure imgf000021_0001
(式中、 Y1 及び Y2 は、 それぞれ水素原子、 ハロゲン原子、 ヒドロカルビル基 、 ヒドロキシル基、 ヒドロカルビルォキシ基、 カルボキシル基又はヒドロカルビ ルォキシカルボ二ル基を示し、 それらはたがいに同一でも異なっていてもよい。(In the formula, Y 1 and Y 2 each represent a hydrogen atom, a halogen atom, a hydrocarbyl group, a hydroxyl group, a hydrocarbyloxy group, a carboxyl group, or a hydrocarboxycarbonyl group, and they may be the same or different. Good.
) で表される 2— ( 2—メチルァダマンチル) — ーァダマンチルメタン系化 合物。 2) (2-methyladamantyl) — adamantyl methane compound represented by).
2. 2 - ( 2—メチルァダマンチル) — —ァダマンチルメタンである請求 項 1記載の 2— ( 2—メチルァダマンチル) 一 2' —ァダマンチルメタン系化合 物。  2. The 2- (2-methyladamantyl) -12'-adamantylmethane compound according to claim 1, which is 2- 2- (2-methyladamantyl) — —adamantylmethane.
3. —般式 ( I ) において、 Y1 及び丫 2 のうちの少なくとも一方がヒドロキシ ル基、 残りが水素原子の 2— ( 2—メチルァダマンチル) — 2' ーァダマンチル メタン水酸化物である請求項 1記載の 2— ( 2—メチルァダマンチル) 一 2' - ァダマンチルメタン系化合物。 3. —In the general formula (I), at least one of Y 1 and 丫2 is a hydroxyl group, and the rest is a hydrogen atom, 2- (2-methyladamantyl) —2′-adamantyl methane hydroxide. 2. The 2- (2-methyladamantyl) -1-2'-adamantyl methane compound according to claim 1.
4. 酸触媒の存在下、 2—メチルー 2—ァダマン夕ノールを脱水二量化したのち 、 水素添加する 2— ( 2—メチルァダマンチル) — 1' —ァダマンチルメタンの 製造方法。  4. A method for producing 2- (2-methyladamantyl) -1'-adamantylmethane, in which 2-methyl-2-adamantyl is dehydrated and dimerized in the presence of an acid catalyst, and then hydrogenated.
5. 酸触媒を、 2—メチル _ 2—ァダマンタノ一ルに対して、 1〜 1 0重量%の 割合で使用する請求項 4に記載の 2— ( 2—メチルァダマンチル) 一 2' —ァダ マンチルメタンの製造方法。  5. The 2- (2-methyladamantyl) 1-2 'according to claim 4, wherein the acid catalyst is used in a proportion of 1 to 10% by weight based on 2-methyl_2-adamantanol. Production method of adamantyl methane.
6. 2 - ( 2—メチルァダマンチル) — 2' —ァダマンチルメタンをハロゲン 化する、 一般式 (Π)
Figure imgf000022_0001
6. 2- (2-Methyladamantyl) — 2'-adamantyl Halogenation of methane, general formula (Π)
Figure imgf000022_0001
(式中、 X1 及び X2 は、 少なくとも一方がハロゲン原子で、 残りが水素原子で ある。 ) で表される 2 _ ( 2—メチルァダマンチル) 一 2' —ァダマンチルメ夕 ンハロゲン化物の製造方法。 (Wherein at least one of X 1 and X 2 is a halogen atom and the remainder is a hydrogen atom.) Production of 2 _ (2-methyladamantyl) -1 2'-adamantyl methyl halide Method.
7. 請求項 6に記載の一般式 (11) で表される 2— ( 2—メチルァダマンチル) - 2 ' —ァダマンチルメタンハロゲン化物を原料とし、 その少なくとも一つのハ ロゲン原子を、 ヒ ドロカルビル基、 ヒドロキシル基、 ヒドロカルビルォキシ基、 カルボキシル基又はヒドロカルビルォキシカルボニル基に変換する 2— ( 2—メ チルァダマンチル) 一2' —ァダマンチルメタン誘導体の製造方法。  7. Starting from 2- (2-methyladamantyl) -2′-adamantyl methane halide represented by the general formula (11) according to claim 6, at least one halogen atom is A method for producing a 2- (2-methyl adamantyl) -1,2'-adamantyl methane derivative which is converted into a hydrocarbyl group, a hydroxyl group, a hydrocarbyloxy group, a carboxyl group or a hydrocarbyloxycarbonyl group.
8. 一般式 (VI)  8. General formula (VI)
Figure imgf000022_0002
Figure imgf000022_0002
(式中、 Rは炭素数 2〜 8のアルキル基を示す。 ) で表される新規ビアダマンタ ン誘導体。  (In the formula, R represents an alkyl group having 2 to 8 carbon atoms.) A novel biadamantan derivative represented by the following formula:
9. 一般式 (VI)における Rが、 ェチル基, n—プロピル基, イソプロピル基, n 一ブチル基, ィソブチル基, s e c—ブチル基, t e r t—ブチル基, n—アミ ル基, イソアミル基, n—へキシル基, n—ヘプチル基, n—ォクチル基又はィ ソォクチル基である請求項 8記載の新規ビアダマン夕ン誘導体。  9. In the general formula (VI), R is ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-amyl, isoamyl, n 9. The novel biadaman derivative according to claim 8, which is —hexyl group, n-heptyl group, n-octyl group or isooctyl group.
1 0. 3, 3 ' —ジ n—プロポキシカルボ二ルーし 1 ' —ビアダマンタンで ある請求項 δ記載の新規ビァダマンタン誘導体。  10. The novel biadamantane derivative according to δ, wherein the derivative is 1 0.3,3'-di-n-propoxycarbone 1'-biadamantane.
PCT/JP2001/000355 2000-01-25 2001-01-19 Novel bisadamantane compounds, process for preparing the same, and novel biadamantane derivatives WO2001055063A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2000-15341 2000-01-25
JP2000015341A JP2001206859A (en) 2000-01-25 2000-01-25 New (bis)adamantane-based compound and method for producing the same
JP2000-65930 2000-03-10
JP2000065930A JP2001253853A (en) 2000-03-10 2000-03-10 New biadamantane derivative

Publications (1)

Publication Number Publication Date
WO2001055063A1 true WO2001055063A1 (en) 2001-08-02

Family

ID=26584071

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/000355 WO2001055063A1 (en) 2000-01-25 2001-01-19 Novel bisadamantane compounds, process for preparing the same, and novel biadamantane derivatives

Country Status (1)

Country Link
WO (1) WO2001055063A1 (en)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010010174A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh 1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use
EP2117009A4 (en) * 2007-02-28 2012-04-04 Sumitomo Bakelite Co ORGANIC INSULATING MATERIAL, VARNISH FOR ORGANIC INSULATING FILM USING THE SAME, ORGANIC INSULATING FILM, AND SEMICONDUCTOR DEVICE
US8497281B2 (en) 2009-11-06 2013-07-30 Vitae Pharmaceuticals, Inc. Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
US8637505B2 (en) 2009-02-04 2014-01-28 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8680093B2 (en) 2009-04-30 2014-03-25 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8686149B2 (en) 2010-11-05 2014-04-01 Boehringer-Ingelheim International Gmbh Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
US8703765B2 (en) 2009-06-02 2014-04-22 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
US8735585B2 (en) 2011-08-17 2014-05-27 Boehringer Ingelheim International Gmbh Indenopyridine derivatives
US8748444B2 (en) 2007-12-11 2014-06-10 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
US8754076B2 (en) 2008-07-25 2014-06-17 Vitae Pharmaceuticals, Inc./Boehringer-Ingelheim Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8765780B2 (en) 2008-05-13 2014-07-01 Boehringer Ingelheim International Gmbh Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
US8765744B2 (en) 2010-06-25 2014-07-01 Boehringer Ingelheim International Gmbh Azaspirohexanones
US8829027B2 (en) 2008-10-23 2014-09-09 Boehringer Ingelheim International Gmbh Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
US8835426B2 (en) 2007-02-26 2014-09-16 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1
US8846613B2 (en) 2010-11-02 2014-09-30 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of metabolic disorders
US8846668B2 (en) 2008-07-25 2014-09-30 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8859580B2 (en) 2007-11-16 2014-10-14 Boehringer Ingelheim International Gmbh Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
US8883778B2 (en) 2009-07-01 2014-11-11 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
US8927539B2 (en) 2009-06-11 2015-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
US8933072B2 (en) 2010-06-16 2015-01-13 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
US9079861B2 (en) 2007-11-07 2015-07-14 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3378587A (en) * 1963-03-14 1968-04-16 Du Pont 3, 3'-diaminomethyl-1, 1'-biadamantane
US4043927A (en) * 1972-03-07 1977-08-23 Sun Ventures, Inc. Friction or tractive drive containing ethers of adamantanes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3378587A (en) * 1963-03-14 1968-04-16 Du Pont 3, 3'-diaminomethyl-1, 1'-biadamantane
US4043927A (en) * 1972-03-07 1977-08-23 Sun Ventures, Inc. Friction or tractive drive containing ethers of adamantanes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FRY J.L. ET AL.: "Dehydration products from 2-methyl-2-adamantanol", COLLECT. CZECH. CHEM. COMMUN., vol. 40, no. 7, 1975, pages 2173 - 2178, XP002939790 *

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8835426B2 (en) 2007-02-26 2014-09-16 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1
EP2117009A4 (en) * 2007-02-28 2012-04-04 Sumitomo Bakelite Co ORGANIC INSULATING MATERIAL, VARNISH FOR ORGANIC INSULATING FILM USING THE SAME, ORGANIC INSULATING FILM, AND SEMICONDUCTOR DEVICE
US9079861B2 (en) 2007-11-07 2015-07-14 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
US8859580B2 (en) 2007-11-16 2014-10-14 Boehringer Ingelheim International Gmbh Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
US8748444B2 (en) 2007-12-11 2014-06-10 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
US8765780B2 (en) 2008-05-13 2014-07-01 Boehringer Ingelheim International Gmbh Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
US9073870B2 (en) 2008-05-13 2015-07-07 Boehringer Ingelheim International Gmbh Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
US8846668B2 (en) 2008-07-25 2014-09-30 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8309597B2 (en) 2008-07-25 2012-11-13 Boehringer Ingelheim International Gmbh 1,1′-diadamantyl carboxylic acids, medicaments containing such compounds and their use
JP2011529031A (en) * 2008-07-25 2011-12-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 1,1'-diadamantylcarboxylic acid, medicament containing such compounds and use thereof
WO2010010174A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh 1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use
US8754076B2 (en) 2008-07-25 2014-06-17 Vitae Pharmaceuticals, Inc./Boehringer-Ingelheim Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8829027B2 (en) 2008-10-23 2014-09-09 Boehringer Ingelheim International Gmbh Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
US8637505B2 (en) 2009-02-04 2014-01-28 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8680093B2 (en) 2009-04-30 2014-03-25 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8703765B2 (en) 2009-06-02 2014-04-22 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
US8927539B2 (en) 2009-06-11 2015-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
US8883778B2 (en) 2009-07-01 2014-11-11 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
US9328072B2 (en) 2009-11-06 2016-05-03 Vitae Pharmaceuticals, Inc. Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
US8497281B2 (en) 2009-11-06 2013-07-30 Vitae Pharmaceuticals, Inc. Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
US9663470B2 (en) 2009-11-06 2017-05-30 Vitae Pharmaceuticals, Inc. Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
US8933072B2 (en) 2010-06-16 2015-01-13 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
US9090605B2 (en) 2010-06-16 2015-07-28 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
US8765744B2 (en) 2010-06-25 2014-07-01 Boehringer Ingelheim International Gmbh Azaspirohexanones
US8846613B2 (en) 2010-11-02 2014-09-30 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of metabolic disorders
US9120769B2 (en) 2010-11-05 2015-09-01 Boehringer-Ingelheim International Gmbh Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
US8686149B2 (en) 2010-11-05 2014-04-01 Boehringer-Ingelheim International Gmbh Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
US8975405B2 (en) 2011-08-17 2015-03-10 Boehringer Ingelheim International Gmbh Indenopyridine derivatives
US8735585B2 (en) 2011-08-17 2014-05-27 Boehringer Ingelheim International Gmbh Indenopyridine derivatives

Similar Documents

Publication Publication Date Title
WO2001055063A1 (en) Novel bisadamantane compounds, process for preparing the same, and novel biadamantane derivatives
JP5466927B2 (en) Fluorene polyester oligomer and method for producing the same
TW201114739A (en) Method for manufacturing a tricyclodecane mono-methanol monocarboxylic acid derivative
JP2636042B2 (en) 4,4 '""-dihydroxyquarterphenyl derivative and method for producing the same
JPS63275541A (en) Diacetylene compound
EP0383141B1 (en) Fluorine-containing alpha,omega-bifunctional compounds and process for their production
JP2004149437A (en) Method for producing triarylphosphoniophenolate
JP2001206859A (en) New (bis)adamantane-based compound and method for producing the same
JP4340817B2 (en) Alicyclic diol and method for producing the same
JP4461841B2 (en) Carboxylic acid compound
JP2001072645A (en) Diadamantyl dicarboxylate compound
JP3360867B2 (en) Method for producing biphenyl-4-carboxylic acid derivative
JP3102282B2 (en) Alicyclic diol compound and method for producing the same
JP4810111B2 (en) Method for producing alcoholate compound
JP2615430B2 (en) Novel polyester and method for producing the same
JP2001253853A (en) New biadamantane derivative
JP5403280B2 (en) Method for producing alicyclic tetracarboxylic acid compound
JP2023177660A (en) Method for producing ruthenium complex, and ruthenium complex and method for producing diamine using the same
JPH01221343A (en) Dihydric phenol compound and its manufacturing method
Song et al. Synthesis and characterization of a novel bicyclic dimer [CuBr (pcadgd)] 2 formed via self-assembly of 4-pyridinecarboxylic acid diethylene glycol diester (pcadgd) with copper (I) bromide
CN115819265A (en) Synthesis method of amide bond-containing lipid
CN115466199A (en) Method for dehydrogenation and esterification of aldehyde and aryl phenol through photo/nickel dual-catalytic system
JPS63264540A (en) Method for producing 1,1'-binaphthyls
JPH03148239A (en) Method for producing carboxylic acid polycyclic alkyl ester
JPH02157245A (en) Production of aromatic carboxylic acid

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): KR US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载